Premium
A NEW MUCOLYTIC, BROMHEXINE (“BISOLVON”) A DOUBLE–BLIND STUDY
Author(s) -
Bateman P. P.
Publication year - 1971
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1971.tb87967.x
Subject(s) - expectorant , medicine , double blind , bronchitis , double blind study , asthma , clinical trial , chronic bronchitis , intensive care medicine , traditional medicine , alternative medicine , placebo , pathology
The pharmacology of expectorants is reviewed, and the need is revealed for a non‐toxic, efficient expectorant. An open clinical trial and a double‐blind controlled trial of bromhexidine in asthma and bronchitis are described and the literature is reviewed, the conclusion being that bromhexine fulfils this need.